Xichen Lin - 15 Mar 2024 Form 4 Insider Report for Structure Therapeutics Inc. (GPCR)

Role
CHIEF SCIENTIFIC OFFICER
Signature
/s/ Jun Yoon, Attorney-in-Fact
Issuer symbol
GPCR
Transactions as of
15 Mar 2024
Net transactions value
$0
Form type
4
Filing time
19 Mar 2024, 16:51:17 UTC
Previous filing
02 Feb 2023
Next filing
05 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GPCR Ordinary Shares Award $0 +85,707 $0.000000 85,707 15 Mar 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GPCR Stock Option (right to buy) Award $0 +213,486 $0.000000 213,486 15 Mar 2024 Ordinary Shares 213,486 $35.25 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one ordinary share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2024, subject to Reporting Person's continued service on such dates.
F2 1/4th of the shares subject to the option shall vest March 1, 2025, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date.